Standout Papers

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia 2011 2026 2016 2021 2.6k
  1. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia (2011)
    David L. Porter, Bruce L. Levine et al. New England Journal of Medicine
  2. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia (2013)
    Stephan A. Grupp, Michael Kalos et al. New England Journal of Medicine
  3. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia (2011)
    Michael Kalos, Bruce L. Levine et al. Science Translational Medicine
  4. Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV (2014)
    Pablo Tebas, David Stein et al. New England Journal of Medicine
  5. Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies (2013)
    Gregory L. Beatty, Andrew R. Haas et al. Cancer Immunology Research
  6. Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells (2012)
    John Scholler, Troy Brady et al. Science Translational Medicine
  7. T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans (2013)
    Marcela V. Maus, Andrew R. Haas et al. Cancer Immunology Research
  8. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy (2013)
    David T. Teachey, Susan R. Rheingold et al. Blood

Immediate Impact

11 by Nobel laureates 65 from Science/Nature 361 standout
Sub-graph 1 of 10

Citing Papers

Principles and therapeutic applications of adaptive immunity
2024 Standout
100 years of the Warburg effect: A cancer metabolism endeavor
2024 Standout
52 intermediate papers

Works of Michael Kalos being referenced

T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
2011 Standout
Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in Humans
2010
and 15 more

Author Peers

Author Last Decade Papers Cites
Michael Kalos 11484 5916 4825 94 15.2k
Michael C. Milone 11138 5721 4395 134 15.1k
Simon F. Lacey 11529 4375 3810 157 14.5k
J. Joseph Melenhorst 10811 3936 3426 121 12.3k
Crystal L. Mackall 9385 4754 3450 146 12.4k
Renier J. Brentjens 14711 6602 5037 194 17.7k
Isabelle Rivière 8876 4211 4079 156 11.8k
Steven A. Feldman 9347 4600 3059 85 11.1k
Barbara Savoldo 13580 6394 4339 204 16.1k
Cameron J. Turtle 8393 3732 2937 162 11.4k
Marcela V. Maus 9657 4734 4801 199 13.3k

All Works

Loading papers...

Rankless by CCL
2026